| Literature DB >> 32209628 |
Maximilian Sohn1, Ayman Agha2, Igors Iesalnieks2, Susanne Bremer2, Stefanie Trum3, Francesca Di Cerbo2, Andreas Nerlich2, Natalie Lotz2, Eckhard Klieser4, Alfred Hochrein5, Philipp Schredl4, Dariya Kalcheva4, Klaus Emmanuel4, Jaroslav Presl4.
Abstract
INTRODUCTION: Diverticulitis is among the most common abdominal disorders. The best treatment strategy for this complicated disease as well as for recurrent stages is still under debate. Moreover, little knowledge exists regarding the effect of different therapeutic strategies on the health-related quality of life (HrQoL). Therefore, the PREDIC-DIV (PREDICtors for health-related quality of life after elective sigmoidectomy for DIVerticular disease) study aims to assess predictors of a change in HrQoL in patients after elective sigmoidectomy for diverticular disease. METHODS AND ANALYSIS: A prospective multicentre transnational observational study was started in November 2017. Patients undergoing elective sigmoid resection for diverticular disease were included. Primary outcome includes HrQoL 6 months postoperatively, staged by the Gastrointestinal Quality of Life Index (GIQLI). Secondary outcomes include HrQoL 6 months after sigmoidectomy, assessed using the Short Form 36 Questionnaire and a custom-made Visual Analogue Scale-based inventory; HrQoL after 12 and 24 months; postoperative morbidity; mortality; influence of surgical technique (conventional laparoscopic multiport operation vs robotic approach); histological grading of inflammation and morphological characteristics of the bowel wall in the resected specimen; postoperative functional changes (faecal incontinence, faecal urge, completeness of emptying, urinary incontinence, sexual function); disease-specific healthcare costs; and changes in economic productivity, measured by the iMTA Productivity Cost Questionnaire. The total follow-up will be 2 years. ETHICS AND DISSEMINATION: The protocol was approved by the medical ethical committee of the Bavarian Medical Council (report identification number: 2017-177). The study was conducted in accordance with the Declaration of Helsinki. The findings of this study will be submitted to a peer-reviewed journal (BMJ Open, Annals of Surgery, British Journal of Surgery, Diseases of the Colon and the Rectum). Abstracts will be submitted to relevant national and international conferences. TRIAL REGISTRATION NUMBER: The study is registered with the ClinicalTrials.gov register as NCT03527706; Pre-results. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: adult surgery; clinical trials; colorectal surgery
Mesh:
Year: 2020 PMID: 32209628 PMCID: PMC7202696 DOI: 10.1136/bmjopen-2019-034385
Source DB: PubMed Journal: BMJ Open ISSN: 2044-6055 Impact factor: 2.692
Figure 1Study flow and inclusion and exclusion criteria.
Secondary outcome parameters
| Outcome parameter | Description/score |
| HrQoL, 6 months postoperatively | SF-36 |
| HrQoL, 6 months postoperatively | A customised VAS-based inventory will be used, composed of six VASs overall, addressing the quality of life and gastrointestinal symptoms (abdominal pain, overall quality of life, bloating, diarrhoea, constipation, influence on quality of life by these symptoms) |
| HrQoL, 12 and 24 months postoperatively | SF-36, GIQLI, VAS |
| Postoperative morbidity | Clavien-Dindo classification |
| Mortality | 30-day mortality and mortality associated with the development of complications related to the recurrence of diverticulitis |
| Postoperative functional changes and associated influence on quality of life |
Faecal incontinence: Wexner score Faecal incomplete emptying and faecal urge (subscales of the Memorial Bowel Function Index, Urinary incontinence: UDI6 Male sexual function: IIEF Female sexual function: FSFI |
| Histopathological and morphological changes of the bowel wall in the resected specimen |
Within the ‘diverticulitis’ region: grading of inflammation (G1–G4) At the colorectal junction: diameter of the bowel wall, total muscular layer, longitudinal versus circular muscular layer, grade of fibrosis, content of Cajal and ganglia cells |
| Disease-specific healthcare costs and days off work | Insurance request |
| Preoperative and postoperative economic productivity | iMTA Productivity Cost Questionnaire |
| Pre-MBP to post-MBP ratio of faecal calprotectin | Faecal calprotectin before MBP and intraoperatively |
| Influence of surgical approach | Comparison of results after conventional laparoscopic multiport operation, robotic approach and conversion to open surgery. |
FSFI, Female Sexual Function Index; GIQLI, Gastrointestinal Quality of Life Index; HrQoL, health-related quality of life; IIEF, International Index of Erectile Function; LARS, low anterior resection syndrome; MBP, mechanical bowel preparation; SF-36, Short Form 36; UDI6, Urinary Distress Inventory; VAS, Visual Analogue Scale.
Classification systems for DD and diverticulitis
| Classification of Diverticular Disease (CDD) | Hinchey-Classification | Modified Hinchey-Classification | ||||||
| Stage | Description | Stage | Description | Stage | Description | |||
| 1 | Uncomplicated diverticulitis | |||||||
| a | Diverticulitis without (inflammatory) reaction in the surrounding tissue | 0 | Mild clinical diverticulitis | |||||
| b | Diverticulitis with phlegmon | I | Pericolic abscess or phlegmon | I | a | Confined pericolic inflammation or phlegmon | ||
| 2 | Complicated diverticulitis (CD) | I | b | Confined pericolic abscess | ||||
| a | CD with micro-abscess (≤ 1 cm) | II | Pelvic, intra-abdominal or retroperito-neal abscess | II | Pelvic, intra-abdominal or retroperitoneal abscess | |||
| b | CD with macro-abscess (> 1 cm) | |||||||
| c | 1 | CD with free perforation and purulent peritonitis | III | Generalized purulent peritonitis | III | Generalized purulent peritonitis | ||
| 2 | CD with free perforation and feculent peritonitis | IV | Generalized feculent peritonitis | IV | Generalized feculent peritonitis | |||
| 3 | Chronic DD | |||||||
| a | Symptomatic DD | |||||||
| b | Recurrent diverticulitis without complications | |||||||
| c | Recurrent diverticulitis with complications | |||||||
| 4 | DD with diverticular bleeding | |||||||
| Ambrosetti Classification | ||||||||
| Stage | Description | |||||||
| Moderate diverticulitis | Localized sigmoid wall thickening (> 5 mm) Pericolic fat stranding | |||||||
| Severe diverticulitis | Abscess Extraluminal air Extraluminal contrast | |||||||
CD, complicated diverticulitis; DD, diverticular disease.